Deficient cotinine formation from nicotine is attributed to the whole deletion of the CYP2A6 gene in humans

被引:97
作者
Nakajima, M
Yamagishi, S
Yamamoto, H
Yamamoto, T
Kuroiwa, Y
Yokoi, T
机构
[1] Kanazawa Univ, Fac Pharmaceut Sci, Div Drug Metab, Kanazawa, Ishikawa 9200934, Japan
[2] Kanazawa Univ, Sch Med, Dept Biochem, Kanazawa, Ishikawa 9200934, Japan
[3] Showa Univ, Sch Pharmaceut Sci, Dept Clin Pharm, Tokyo 142, Japan
关键词
D O I
10.1067/mcp.2000.103957
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nicotine is mainly metabolized to cotinine by cytochrome P450 (CYP) 2A6, Large interindividual differences in nicotine metabolism have been reported in humans. The purpose of this study was to clarify the relationship between the poor metabolism of nicotine and the existence of the C Y P2A6v1 and C Y P2A6v2 alleles, and a whole deletion allele of the C Y P2A6 gene, The plasma concentrations of nicotine and cotinine were measured in 10 healthy subjects after each smoked one cigarette or chewed one piece of nicotine gum. One subject showed no detectable cotinine level in plasma when smoking and the lowest cotinine level when receiving nicotine gum. The subject was regarded as a poor metabolizer of nicotine by a probit analysis and was found to carry a homozygous whole deletion allele of the C Y P2A6 gene. This is the first report to show that deficient cotinine formation in humans is attributed to the whole deletion of the C Y P2A6 gene.
引用
收藏
页码:57 / 69
页数:13
相关论文
共 25 条
[1]  
[Anonymous], 1989, Molecular Cloning: A Laboratory Manual
[2]   CYP2D6 phenotype and the metabolism of nicotine and cotinine [J].
Benowitz, NL ;
Jacob, P ;
PerezStable, E .
PHARMACOGENETICS, 1996, 6 (03) :239-242
[3]  
BENOWITZ NL, 1988, NEW ENGL J MED, V319, P1318
[4]   DEFICIENT C-OXIDATION OF NICOTINE [J].
BENOWITZ, NL ;
JACOB, P ;
SACHS, DPL .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 57 (05) :590-594
[5]  
BENOWITZ NL, 1987, TOBACCO SMOKING NICO, P357
[6]   ENZYME ALDEHYDE OXIDASE IS AN IMINIUM OXIDASE - REACTION WITH NICOTINE DELTA-1'(5')IMINIUM ION [J].
BRANDANGE, S ;
LINDBLOM, L .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1979, 91 (03) :991-996
[7]   POOR METABOLIZERS OF NICOTINE AND CYP2D6 POLYMORPHISM [J].
CHOLERTON, S ;
ARPANAHI, A ;
MCCRACKEN, N ;
BOUSTEAD, C ;
TABER, H ;
JOHNSTONE, E ;
LEATHART, J ;
DALY, AK ;
IDLE, JR .
LANCET, 1994, 343 (8888) :62-63
[8]   THE CYP 2A GENE SUBFAMILY - SPECIES-DIFFERENCES, REGULATION, CATALYTIC ACTIVITIES AND ROLE IN CHEMICAL CARCINOGENESIS [J].
FERNANDEZSALGUERO, P ;
GONZALEZ, FJ .
PHARMACOGENETICS, 1995, 5 :S123-S128
[9]  
FERNANDEZSALGUERO P, 1995, AM J HUM GENET, V57, P651
[10]  
Finney D.J., 1964, Probit Analysis